Arya Sciences Acquisition Corp V Cl A (ARYE)
Arya Sciences Acquisition Corp V Cl A (ARYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 296 | 385 | 419 | 531 | 704 |
| TOTAL | $426 | $542 | $669 | $863 | $1,128 |
| Non-Current Assets | |||||
| Investments And Advances | 153,294 | 151,602 | 150,380 | 149,718 | 149,481 |
| TOTAL | $153,294 | $151,602 | $150,380 | $149,718 | $149,481 |
| Total Assets | $153,720 | $152,144 | $151,049 | $150,581 | $150,609 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 120 | 90 | 60 | N/A | N/A |
| Accounts payable and accrued liabilities | 13 | 12 | 13 | 12 | 55 |
| Accrued Expenses | 2,830 | 2,776 | 2,703 | 2,764 | 2,751 |
| TOTAL | $2,963 | $2,878 | $2,776 | $2,807 | $2,836 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 155,811 | 154,118 | 152,897 | 154,851 | 154,733 |
| TOTAL | $155,811 | $154,118 | $152,897 | $154,851 | $154,733 |
| Total Liabilities | $158,774 | $156,996 | $155,672 | $157,658 | $157,569 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,187 | 19,187 | 19,187 | 19,187 | 19,187 |
| Retained earnings | -5,054 | -4,852 | -4,624 | -7,077 | -6,960 |
| TOTAL | $-5,054 | $-4,852 | $-4,623 | $-7,077 | $-6,960 |
| Total Liabilities And Equity | $153,720 | $152,144 | $151,049 | $150,581 | $150,609 |